Therefore, the inclusion of additional patients with different renal diseases and CKD stages would increase statistical power and might help to unravel the role of TFF2 in the acute phase of renal failure and during progression to end-stage renal disease. The gene discussed is TFF2; the disease is stage 5 chronic kidney disease.